The DOI matches its Crossref record; 62 of the 64 references it cites were found in a registry or an index.
The Metabolic Profile of Tumors Depends on Both the Responsible Genetic Lesion and Tissue Type
Open accessAbstract
The altered metabolism of tumors has been considered a target for anticancer therapy. However, the relationship between distinct tumor-initiating lesions and anomalies of tumor metabolism in vivo has not been addressed. We report that MYC-induced mouse liver tumors significantly increase both glucose and glutamine catabolism, whereas MET-induced liver tumors use glucose to produce glutamine. Increased glutamine catabolism in MYC-induced liver tumors is associated with decreased levels of glutamine synthetase (Glul) and the switch from Gls2 to Gls1 glutaminase. In contrast to liver tumors, MYC-induced lung tumors display increased expression of both Glul and Gls1 and accumulate glutamine. We also show that inhibition of Gls1 kills cells that overexpress MYC and catabolize glutamine. Our results suggest that the metabolic profiles of tumors are likely to depend on both the genotype and tissue of origin and have implications regarding the design of therapies targeting tumor metabolism.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Importantly, inhibiting glutamine entry into the TCA cycle can blunt tumor progression in a MYC-driven cancer model of liver cancer (Xiang et al., 2015; Yuneva et al., 2012) and a MYC-inducible Burkitt lymphoma model (Le et al., 2012; Xiang et al., 2015).”
From Targeting Metabolism for Cancer Therapy (2017) · cites this paper as Yuneva et al., 2012
In the citing paper
“MYC has been found to increase mRNA and protein levels of glutamine transporters as well as expression of the enzyme glutaminase, which catalyzes the first step in glutaminolysis (Gao et al., 2009; Wise et al., 2008; Yuneva et al., 2012).”
From Targeting Metabolism for Cancer Therapy (2017) · cites this paper as Yuneva et al., 2012
In the citing paper
“Second, although different oncogenes reprogram metabolism in different ways, the tissue in which the oncogene is expressed affects the execution of metabolic reprogramming.”
From Metabolic reprogramming and cancer progression (2020) · cites this paper as [5]
In the citing paper
“Transgenic MYC induces metabolic changes in both liver tumors and lung tumors but activates glutamine catabolism in lung tumors and glutamine synthesis in liver tumors.”
From Metabolic reprogramming and cancer progression (2020) · cites this paper as [5]
In the citing paper
“MYC-driven cancer cells exhibit enhanced glutamine utilization accompanied by increased expression of key glutaminolysis enzymes, including GLS1/GLS2 and GLUD1178–180.”
From Glutamine reliance in cell metabolism (2020) · cites this paper as [179]
In the citing paper
“For example, liver tumors with aberrant overexpression of MYC display enhanced glutamine oxidation and sensitivity to therapies that target glutamine catabolism relative to liver tumors driven by overexpression of MET (196).”
From Regulation and function of the mammalian tricarboxylic acid cycle (2023) · cites this paper as [196]
In the citing paper
“furthermore, a similar accumulation of glucose-derived glutamine within the tumor tissue was observed in a mouse model of c-Met-driven liver cancer (Yuneva et al., 2012).”
From The emerging hallmarks of cancer metabolism (2016) · cites this paper as Yuneva et al., 2012
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Warburg, O. (1956) · Science · doi:10.1126/science.123.3191.309 · Cited by 13,425
Why Do Cancers Have High Aerobic Glycolysis?
Gatenby, R. A., & Gillies, R. J. (2004) · Nature reviews. Cancer · doi:10.1038/nrc1478 · Cited by 4,784
Cancer genes and the pathways they control
Vogelstein, B., & Kinzler, K. W. (2004) · Nature Medicine · doi:10.1038/nm1087 · Cited by 4,346
The Biology of Cancer: Metabolic Reprogramming Fuels Cell Growth and Proliferation
DeBerardinis, R. J., Lum, J. J., Hatzivassiliou, G., & Thompson, C. B. (2008) · Cell Metabolism · doi:10.1016/j.cmet.2007.10.002 · Cited by 4,088
Gao, P., Tchernyshyov, I., Chang, T.-C., Lee, Y.-S., Kita, K., Ochi, T., Zeller, K. I., De Marzo, A. M., Van Eyk, J. E., Mendell, J. T., et al. (2009) · Nature · doi:10.1038/nature07823 · Cited by 2,124
Wise, D. R., DeBerardinis, R. J., Mancuso, A., Sayed, N., Zhang, X.-Y., Pfeiffer, H. K., Nissim, I., Daikhin, E., Yudkoff, M., McMahon, S. B., et al. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0810199105 · Cited by 2,001
Bidirectional Transport of Amino Acids Regulates mTOR and Autophagy
Nicklin, P., Bergman, P., Zhang, B., Triantafellow, E., Wang, H., Nyfeler, B., Yang, H., Hild, M., Kung, C., Wilson, C., et al. (2009) · Cell · doi:10.1016/j.cell.2008.11.044 · Cited by 1,798
Wnt signalling and its impact on development and cancer
Klaus, A., & Birchmeier, W. (2008) · Nature Reviews Cancer · doi:10.1038/nrc2389 · Cited by 1,595
Reflecting on 25 years with MYC
Meyer, N., & Penn, L. Z. (2008) · Nature Reviews Cancer · doi:10.1038/nrc2231 · Cited by 1,575
Molecular pathogenesis of human hepatocellular carcinoma
Thorgeirsson, S. S., & Grisham, J. W. (2002) · Nature Genetics · doi:10.1038/ng0802-339 · Cited by 1,456
Q's next: the diverse functions of glutamine in metabolism, cell biology and cancer
DeBerardinis, R. J., & Cheng, T. (2010) · Oncogene · doi:10.1038/onc.2009.358 · Cited by 1,365
Widespread microRNA repression by Myc contributes to tumorigenesis
Chang, T.-C., Yu, D., Lee, Y., Wentzel, E. A., Arking, D. E., West, K. M., Dang, C. V., Thomas‐Tikhonenko, A., & Mendell, J. T. (2007) · Nature Genetics · doi:10.1038/ng.2007.30 · Cited by 1,346
Organelle isolation: functional mitochondria from mouse liver, muscle and cultured filroblasts
Frezza, C., Cipolat, S., & Scorrano, L. (2007) · Nature Protocols · doi:10.1038/nprot.2006.478 · Cited by 1,188
Somatic mutations of the β-catenin gene are frequent in mouse and human hepatocellular carcinomas
Coste, A. D. L., Romagnolo, B., Billuart, P., Renard, C.-A., Buendia, M., Soubrane, O., Fabrè, M., Chelly, J., Beldjord, C., Kahn, A., et al. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.15.8847 · Cited by 1,157
Deregulation of Glucose Transporter 1 and Glycolytic Gene Expression by c-Myc
Osthus, R. C., Shim, H., Kim, S., Li, Q., Reddy, R., Mukherjee, M., Xu, Y., Wonsey, D. R., Lee, L. A., & Dang, C. V. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.c000023200 · Cited by 876
MYC inactivation uncovers pluripotent differentiation and tumour dormancy in hepatocellular cancer
Shachaf, C. M., Kopelman, A. M., Arvanitis, C., Karlsson, Å., Beer, S., Mandl, S., Bachmann, M. H., Borowsky, A. D., Ruebner, B., Cardiff, R. D., et al. (2004) · Nature · doi:10.1038/nature03043 · Cited by 874
Self-citationDeficiency in glutamine but not glucose induces MYC-dependent apoptosis in human cells
Yuneva, M., Zamboni, N., Oefner, P., Sachidanandam, R., & Lazebnik, Y. (2007) · The Journal of Cell Biology · doi:10.1083/jcb.200703099 · Cited by 690 · cited 8×
“(IMR90-ERMYC and HA1E-MYCER) that can be activated by 4-hydroxytamoxifen (OHT) (Yuneva et al., 2007), as well as HA1E cells that constitutively overexpress wild-type MYC (HA1E-MYC).”
BackgroundMethodInfluentialSelf-citationRegulation of Glutaminase Activity and Glutamine Metabolism
Curthoys, N. P., & Watford, M. (1995) · Annual Review of Nutrition · doi:10.1146/annurev.nu.15.070195.001025 · Cited by 676
Pyruvate carboxylase is required for glutamine-independent growth of tumor cells
Cheng, T., Sudderth, J., Yang, C., Mullen, A. R., Jin, E. S., Matés, J. M., & DeBerardinis, R. J. (2011) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1016627108 · Cited by 475
Self-citationDistinct Thresholds Govern Myc's Biological Output In Vivo
Murphy, D. J., Junttila, M. R., Pouyet, L., Karnezis, A., Shchors, K., Bui, D. A., Brown-Swigart, L., Johnson, L., & Evan, G. I. (2008) · Cancer Cell · doi:10.1016/j.ccr.2008.10.018 · Cited by 456
Impact of animal handling on the results of 18F-FDG PET studies in mice.
Fueger, B. J., Czernin, J. G., Hildebrandt, I. J., Tran, C., Halpern, B. S., Stout, D., Phelps, M. E., & Weber, W. (2006) · PubMed · Cited by 455
Fan, T. W. ‐., Lane, A. N., Higashi, R. M., Farag, M. A., Gao, H. T., Bousamra, M., & Miller, D. M. (2009) · Molecular Cancer · doi:10.1186/1476-4598-8-41 · Cited by 438
Self-citationNew targets of β-catenin signaling in the liver are involved in the glutamine metabolism
Cadoret, A., Ovejero, C., Terris, B., Souil, E., Lévy, L., Lamers, W. H., Kitajewski, J., Kahn, A., & Perret, C. (2002) · Oncogene · doi:10.1038/sj.onc.1206118 · Cited by 412
Kaposi-Novák, P. (2006) · Journal of Clinical Investigation · doi:10.1172/jci27236 · Cited by 405
(2017) · Elsevier eBooks · doi:10.1016/c2014-1-04056-2 · Cited by 377
LACTIC DEHYDROGENASE IN HUMAN NEOPLASTIC TISSUES.
Goldman, R. D., Kaplan, N. O., & Hall, T. C. (1964) · PubMed · Cited by 355
Robinson, M. M., McBryant, S. J., Tsukamoto, T., Rojas, C. J., Ferraris, D. V., Hamilton, S. K., Hansen, J. C., & Curthoys, N. P. (2007) · Biochemical Journal · doi:10.1042/bj20070039 · Cited by 344
Self-citationBustamante, E., Morris, H. P., & Pedersen, P. L. (1981) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)68900-3 · Cited by 319
Glycolysis, glutaminolysis and cell proliferation
McKeehan, W. L. (1982) · Cell Biology International Reports · doi:10.1016/0309-1651(82)90125-4 · Cited by 305
Wang, R., Ferrell, L. D., Faouzi, S., Maher, J. J., & Bishop, J. M. (2001) · The Journal of Cell Biology · doi:10.1083/jcb.153.5.1023 · Cited by 291
Self-citationKung, H.-N., Marks, J. R., & Chi, J.-T. (2011) · PLoS Genetics · doi:10.1371/journal.pgen.1002229 · Cited by 277
Deviant energetic metabolism of glycolytic cancer cells
Baggetto, L. G. (1992) · Biochimie · doi:10.1016/0300-9084(92)90016-8 · Cited by 268
Caspases Disrupt the Nuclear-Cytoplasmic Barrier
Faleiro, L. J., & Lazebnik, Y. A. (2000) · The Journal of Cell Biology · doi:10.1083/jcb.151.5.951 · Cited by 249
Recent Molecular Advances in Mammalian Glutamine Transport
Bode, B. P. (2001) · Journal of Nutrition · doi:10.1093/jn/131.9.2475s · Cited by 245
植木, 孝., Fujimoto, J., Suzuki, T., Yamamoto, H., & Okamoto, E. (1997) · Hepatology · doi:10.1002/hep.510250413 · Cited by 225
Distinct pathways of genomic progression to benign and malignant tumors of the liver
Tward, A. D., Jones, K. D., Yant, S. R., Cheung, S., Fan, S. T., Chen, X., Kay, M. A., Wang, R., & Bishop, J. M. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0706578104 · Cited by 217
Self-citationAn enzymatic approach to lactate production in human skeletal muscle during exercise
Spriet, L. L., Howlett, R. A., & Heigenhauser, G. J. F. (2000) · Medicine & Science in Sports & Exercise · doi:10.1097/00005768-200004000-00007 · Cited by 207
Determining and understanding the control of glycolysis in fast‐growth tumor cells
Marín‐Hernández, Á., Rodríguez‐Enríquez, S., Vital‐González, P. A., Flores‐Rodríguez, F. L., Macías‐Silva, M., Sosa‐Garrocho, M., & Moreno‐Sánchez, R. (2006) · FEBS Journal · doi:10.1111/j.1742-4658.2006.05214.x · Cited by 203
Central Role of c-Myc during Malignant Conversion in Human Hepatocarcinogenesis
Kaposi-Novák, P., Libbrecht, L. J., Woo, H. G., Lee, Y., Sears, N. C., Conner, E. A., Factor, V. M., Roskams, T., & Thorgeirsson, S. S. (2009) · Cancer Research · doi:10.1158/0008-5472.can-08-3357 · Cited by 188
Medina, M. Á. (2001) · Journal of Nutrition · doi:10.1093/jn/131.9.2539s · Cited by 182
Stable isotope resolved metabolomics of lung cancer in a SCID mouse model
Fan, T. W. ‐., Lane, A. N., Higashi, R. M., & Yan, J. (2010) · Metabolomics · doi:10.1007/s11306-010-0249-0 · Cited by 115
Self-citationGlycolytic enzymes as DNA binding proteins
Ronai, Z. A. (1993) · International Journal of Biochemistry · doi:10.1016/0020-711x(93)90123-v · Cited by 106
Co-expression of glutaminase K and L isoenzymes in human tumour cells
Pérez‐Gómez, C., Campos-Sandoval, J. A., Alonso, F. J., SEGURA, J. A., Manzanares, E., RUIZ-SÁNCHEZ, P., GONZÁLEZ, M. E., Márquez, J., & Matés, J. M. (2005) · Biochemical Journal · doi:10.1042/bj20040996 · Cited by 104
Self-citationMaRX: An Approach to Genetics in Mammalian Cells
Hannon, G. J., Sun, P., Carnero, A., Xie, L. Y., Maestro, R., Conklin, D. S., & Beach, D. (1999) · Science · doi:10.1126/science.283.5405.1129 · Cited by 93
Chafey, P., Finzi, L., Boisgard, R., Caüzac, M., Clary, G., Broussard, C., Pégorier, J., Guillonneau, F., Mayeux, P., Camoin, L., et al. (2009) · Proteomics · doi:10.1002/pmic.200800609 · Cited by 90
Vora, S., Halper, J. P., & Knowles, D. M. (1985) · PubMed · Cited by 89
Tran, P. T., Fan, A. C., Bendapudi, P. K., Koh, S., Komatsubara, K. M., Chen, J., Horng, G., Bellovin, D. I., Giuriato, S., Wang, C. S., et al. (2008) · PLoS ONE · doi:10.1371/journal.pone.0002125 · Cited by 87
Self-citationNitrogen metabolism in tumor bearing mice
Márquez, J., Sánchez-Jiménez, F., Medina, M. A., Quesada, A. R., & de Castro, I. N. (1989) · Archives of Biochemistry and Biophysics · doi:10.1016/0003-9861(89)90335-4 · Cited by 86
Yokota, J., Wada, M., Yoshida, T., Noguchi, M., Terasaki, T., Shimosato, Y., Sugimura, T., & Terada, M. (1989) · Lung Cancer · doi:10.1016/0169-5002(89)90332-2 · Cited by 82
Hastak, K., Paul, R. K., Agarwal, M. K., Thakur, V. S., Amin, A. R. M. R., Agrawal, S., Sramkoski, R. M., Jacobberger, J. W., Jackson, M. W., Stark, G. R., et al. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0802080105 · Cited by 79
Pathways from glutamine to apoptosis
Matés, J. M. (2006) · Frontiers in bioscience · doi:10.2741/2040 · Cited by 75
Self-citationYuneva, M. O. (2008) · Cell Cycle · doi:10.4161/cc.7.14.6256 · Cited by 73
Self-citationp53 genetic abnormalities and myc activation in human lung carcinoma
Gazzéri, S., Brambilla, E. M., de Fromentel, C. C., Gouyer, V., Moro‐Sibilot, D., Perron, P., Berger, F. R., & Brambilla, C. (1994) · International Journal of Cancer · doi:10.1002/ijc.2910580106 · Cited by 70
Perdomo, G., Martínez‐Brocca, M. A., Bhatt, B. A., Brown, N. F., O'Doherty, R. M., & Garcı́a-Ocaña, A. (2008) · Journal of Biological Chemistry · doi:10.1074/jbc.m707551200 · Cited by 66
Glutamate production by HIV‐1 infected human macrophage is blocked by the inhibition of glutaminase
Erdmann, N. B., Zhao, J., Lopez, A. L., Herek, S., Curthoys, N. P., Hexum, T. D., Tsukamoto, T., Ferraris, D. V., & Zheng, J. (2007) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2007.04594.x · Cited by 53
Self-citationInteraction between MYC and MCL1 in the Genesis and Outcome of Non–Small-Cell Lung Cancer
Allen, T. D., Zhu, C., Jones, K. D., Yanagawa, N., Tsao, M., & Bishop, J. M. (2011) · Cancer Research · doi:10.1158/0008-5472.can-10-3590 · Cited by 47
Self-citationHGF/SF Activates Glycolysis and Oxidative Phosphorylation in DA3 Murine Mammary Cancer Cells
Kaplan, O., Firon, M., Vivi, A., Navon, G., & Tsarfaty, I. (2000) · Neoplasia · doi:10.1038/sj.neo.7900103 · Cited by 36
Schwartz, J. L., Jordan, R. T., Liber, H. L., Murnane, J. P., & Evans, H. H. (2001) · Genes Chromosomes and Cancer · doi:10.1002/1098-2264(2000)9999:9999 · Cited by 27
Glucocorticoids regulate glutamine synthetase expression in lung epithelial cells
Abcouwer, S. F., Lukaszewicz, G. C., & Souba, W. W. (1996) · American Journal of Physiology-Lung Cellular and Molecular Physiology · doi:10.1152/ajplung.1996.270.1.l141 · Cited by 25
Isolated mouse liver mitochondria are devoid of glucokinase
Bustamante, E., Pediaditakis, P., He, L., & Lemasters, J. J. (2005) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2005.06.174 · Cited by 18
Metabolomics-Edited Transcriptomics Analysis (META)
Fan, T. W. ‐. (2012) · Methods in pharmacology and toxicology · doi:10.1007/978-1-61779-618-0_14 · Cited by 13
Self-citationGenomic Progression in Mouse Models for Liver TumorsPreprint
Tward, A. D., Jones, K. D., Yant, S. R., Kay, M. A., WANG, R., & Bishop, J. M. (2005) · Cold Spring Harbor Symposia on Quantitative Biology · doi:10.1101/sqb.2005.70.058 · Cited by 13
Self-citation
Cited by
Sorted by citations
The emerging hallmarks of cancer metabolism
Pavlova, N. N., & Thompson, C. B. (2016) · Cell Metabolism · doi:10.1016/j.cmet.2015.12.006 · Cited by 5,926
Fundamentals of Cancer Metabolism
DeBerardinis, R. J., & Chandel, N. S. (2016) · Science Advances · doi:10.1126/sciadv.1600200 · Cited by 3,013
Metabolic reprogramming and cancer progression
Faubert, B., Solmonson, A., & DeBerardinis, R. J. (2020) · Science · doi:10.1126/science.aaw5473 · Cited by 2,740
Understanding the Intersections between Metabolism and Cancer Biology
Heiden, M. G. V., & DeBerardinis, R. J. (2017) · Cell · doi:10.1016/j.cell.2016.12.039 · Cited by 2,369
From Krebs to clinic: glutamine metabolism to cancer therapy
Altman, B. J., Stine, Z. E., & Dang, C. V. (2016) · Nature Reviews Cancer · doi:10.1038/nrc.2016.71 · Cited by 2,119
Metadata
- Authors
- Yuneva, M. O., Fan, T. W. M., Allen, T. D., Higashi, R. M., Ferraris, D. V., Tsukamoto, T., Matés, J. M., Alonso, F. J., Wang, C., Seo, Y., Chen, X., & Bishop, J. M.
- Affiliations
- University of California, San Francisco (US)
- University of Louisville (US)
- Johns Hopkins University (US)
- Universidad de Málaga (ES)
- Corresponding author
- Yuneva, Mariia O.
- ORCID
- Venue
- Cell Metabolism
- Publisher
- Elsevier BV
- Published
- 2012-02
- Volume
- 15
- Issue
- 2
- Pages
- 157-170
- ISSN
- 1550-4131 (ISSN-L)
- PMC
- PMC3282107
- OpenAlex
- W2036659083
- Cited by
- 639
- References
- 64
- Citations by year
- 2026: 17 · 2025: 37 · 2024: 35 · 2023: 41 · 2022: 53 · 2021: 66 · 2020: 43 · 2019: 59 · 2018: 45 · 2017: 63 · 2016: 47 · 2015: 39 · 2014: 42 · 2013: 34 · 2012: 16
- FWCI
- 13.97
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Licence
- Locations
- Cell Metabolism (publishedVersion)
- PubMed (publishedVersion)
- Europe PMC (PubMed Central) (acceptedVersion)
- PubMed Central (acceptedVersion)
- Funders
- National Cancer Institute (R35CA044338, R01CA118434)
- National Institute of Neurological Disorders and Stroke (R21NS074151)
- National Center for Research Resources (P20RR018733)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Cancer, Hypoxia, and Metabolism
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Biochemistry › Amino Acid Enzymes and Metabolism
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Metabolism, Diabetes, and Cancer
- Keywords
- cancer metabolism, c-Myc, MET, glutamine catabolism, glutamine synthetase, glutaminase, GLS1, GLS2, liver tumors, lung cancer, genetic lesions, glutamine accumulation
- MeSH terms
- Animals, Cell Transformation, Neoplastic, Citric Acid Cycle, Glucokinase, Glucose, Glutamine, Humans, Immunohistochemistry, Isotope Labeling, Liver Neoplasms, Experimental, Lung Neoplasms, Immunoblotting, Blotting, Western, Proto-Oncogene Proteins c-myc, DNA Primers, Lactic Acid, Proto-Oncogene Proteins c-met, Nuclear Magnetic Resonance, Biomolecular, RNA Interference, Cell Line, Tumor, Mice, Metabolome
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
